1H. Gakiopoulou,N. Givalos,G. Liapis,G. Agrogiannis,E. Patsouris,I. Delladetsima.Hepatoid Adenocarcinoma of the Gallbladder[J].Digestive Diseases and Sciences.2007(12)
2A. Lopez-Beltran,R. J. Luque,A. Quintero,M. J. Requena,R. Montironi.Hepatoid adenocarcinoma of the urinary bladder[J].Virchows Archiv.2003(4)
3G. Bombski,A. Gasiorowska,D. Orszulak-Michalak,B. Neneman,J. Kotynia,J. Strzelczyk,A. Janiak,E. Malecka-Panas.Elevated plasma gastrin, CEA, and CA 19-9 levels decrease after colorectal cancer resection[J].International Journal of Colorectal Disease.2003(2)
4Satoshi Inagawa,Jiro Shimazaki,Masao Hori,Fuyo Yoshimi,Shinya Adachi,Toru Kawamoto,Katashi Fukao,Masayuki Itabashi.Hepatoid adenocarcinoma of the stomach[J].Gastric Cancer.2001(1)
5Z. Fan,M. Rijin,K. Montogomery,R.V. Rouse.Hep Par1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections[].Modern Pathology.2003
6Porcell AI,De —Young BR,ProcaDM,et al.Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver:MOC31 compares favorably with other putative markers[].Modern Pathology.2000
7F Naghibalhossaini,P Ebadi.Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme[].Cancer Letters.2006
8MJ Lee,HS Lee,WH Kim,Y Choi,MH Yang.Expression of mucins and cytokeratins in primary carcinomas of the digestive system[].Modern Pathology.2003
9Lau SK,Prakash S,Geller SA,Alsabeh R.Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma[].Human Pathology.2002
10S. Kakar,T. Muir,L.M. Murphy,R.V. Lloyd,L.J. Burgart.Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma[].American Journal of Clinical Pathology.2003
